FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028551736> ?p ?o ?g. }

• W3028551736 endingPage "1316" @default.
• W3028551736 startingPage "1316" @default.
• W3028551736 abstract "The goal of this study was to assess how PD-L1 expression in tissue specimens of patients with main molecular subtypes of NMIBC (luminal, basal and double-negative p53-mutant) associates with relapsed-free survival in dependence on the tumor grade and prior treatment of primary bladder cancer. PD-L1 expressions on the membrane of neoplastic and CD8+ immune cells were assessed in tumor specimens (n = 240) of primary and relapsed luminal, basal and double-negative p53-mutant NMIBC. Association between relapse-free survival and PD-L1 expression was estimated for high- and low-grade relapsed NMIBC according to previous treatment and their molecular profile, using the Kaplan–Meier method, and assessed by using the log-rank test. Potential confounders were adjusted by Cox regression models. In a group of patients who underwent only TUR without intravesical therapy, there were significant differences in relapse time between high- and low-grade tumors in basal and luminal molecular subtypes; for basal relapsed carcinoma, RFS was shorter in cases where tumors were less malignant. Both intravesical mitomycin and Bacillus Calmette–Guerin (BCG) therapy significantly extended the time of recurrence of low-grade luminal and basal bladder malignancies with no intergroup differences in double-negative NMIBC. PD-L1 expression status was associated with RFS for luminal relapsed NMIBCs in the group without previous frontline intervention, and with RFS in the group of patients with luminal relapsed bladder cancer previously utilized BCG. Obtained results may be considered as a promising approach for further clinical implementation." @default.
• W3028551736 created "2020-05-29" @default.
• W3028551736 creator A5002051608 @default.
• W3028551736 creator A5004619187 @default.
• W3028551736 creator A5008256485 @default.
• W3028551736 creator A5010613335 @default.
• W3028551736 creator A5014526707 @default.
• W3028551736 creator A5021600648 @default.
• W3028551736 creator A5032679795 @default.
• W3028551736 creator A5045851159 @default.
• W3028551736 creator A5051276233 @default.
• W3028551736 creator A5060266529 @default.
• W3028551736 creator A5065829619 @default.
• W3028551736 creator A5076537438 @default.
• W3028551736 creator A5082384752 @default.
• W3028551736 creator A5083317682 @default.
• W3028551736 creator A5091616017 @default.
• W3028551736 date "2020-05-21" @default.
• W3028551736 modified "2023-09-27" @default.
• W3028551736 title "Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy" @default.
• W3028551736 cites W1568317937 @default.
• W3028551736 cites W1847493486 @default.
• W3028551736 cites W1972882573 @default.
• W3028551736 cites W1983093014 @default.
• W3028551736 cites W2018968534 @default.
• W3028551736 cites W2033775272 @default.
• W3028551736 cites W2045078221 @default.
• W3028551736 cites W2066671159 @default.
• W3028551736 cites W2073571081 @default.
• W3028551736 cites W2097995306 @default.
• W3028551736 cites W2136859769 @default.
• W3028551736 cites W2150544967 @default.
• W3028551736 cites W2252644942 @default.
• W3028551736 cites W2414977199 @default.
• W3028551736 cites W2424595837 @default.
• W3028551736 cites W2509266256 @default.
• W3028551736 cites W2559495611 @default.
• W3028551736 cites W2560367415 @default.
• W3028551736 cites W2607934365 @default.
• W3028551736 cites W2609082277 @default.
• W3028551736 cites W2609464379 @default.
• W3028551736 cites W2610674682 @default.
• W3028551736 cites W2742201386 @default.
• W3028551736 cites W2770258498 @default.
• W3028551736 cites W2799632934 @default.
• W3028551736 cites W2810119577 @default.
• W3028551736 cites W2900317915 @default.
• W3028551736 cites W2947305217 @default.
• W3028551736 cites W2970921484 @default.
• W3028551736 cites W4243797664 @default.
• W3028551736 doi "https://doi.org/10.3390/cancers12051316" @default.
• W3028551736 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7281187" @default.
• W3028551736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32455829" @default.
• W3028551736 hasPublicationYear "2020" @default.
• W3028551736 type Work @default.
• W3028551736 sameAs 3028551736 @default.
• W3028551736 citedByCount "4" @default.
• W3028551736 countsByYear W30285517362020 @default.
• W3028551736 countsByYear W30285517362021 @default.
• W3028551736 countsByYear W30285517362023 @default.
• W3028551736 crossrefType "journal-article" @default.
• W3028551736 hasAuthorship W3028551736A5002051608 @default.
• W3028551736 hasAuthorship W3028551736A5004619187 @default.
• W3028551736 hasAuthorship W3028551736A5008256485 @default.
• W3028551736 hasAuthorship W3028551736A5010613335 @default.
• W3028551736 hasAuthorship W3028551736A5014526707 @default.
• W3028551736 hasAuthorship W3028551736A5021600648 @default.
• W3028551736 hasAuthorship W3028551736A5032679795 @default.
• W3028551736 hasAuthorship W3028551736A5045851159 @default.
• W3028551736 hasAuthorship W3028551736A5051276233 @default.
• W3028551736 hasAuthorship W3028551736A5060266529 @default.
• W3028551736 hasAuthorship W3028551736A5065829619 @default.
• W3028551736 hasAuthorship W3028551736A5076537438 @default.
• W3028551736 hasAuthorship W3028551736A5082384752 @default.
• W3028551736 hasAuthorship W3028551736A5083317682 @default.
• W3028551736 hasAuthorship W3028551736A5091616017 @default.
• W3028551736 hasBestOaLocation W30285517361 @default.
• W3028551736 hasConcept C121608353 @default.
• W3028551736 hasConcept C126322002 @default.
• W3028551736 hasConcept C126894567 @default.
• W3028551736 hasConcept C142724271 @default.
• W3028551736 hasConcept C143998085 @default.
• W3028551736 hasConcept C204232928 @default.
• W3028551736 hasConcept C2777701055 @default.
• W3028551736 hasConcept C2778024521 @default.
• W3028551736 hasConcept C2779306644 @default.
• W3028551736 hasConcept C2780352672 @default.
• W3028551736 hasConcept C2781197716 @default.
• W3028551736 hasConcept C502942594 @default.
• W3028551736 hasConcept C50382708 @default.
• W3028551736 hasConcept C55493867 @default.
• W3028551736 hasConcept C71924100 @default.
• W3028551736 hasConcept C86803240 @default.
• W3028551736 hasConceptScore W3028551736C121608353 @default.
• W3028551736 hasConceptScore W3028551736C126322002 @default.
• W3028551736 hasConceptScore W3028551736C126894567 @default.
• W3028551736 hasConceptScore W3028551736C142724271 @default.
• W3028551736 hasConceptScore W3028551736C143998085 @default.

• next